Joel Greenblatt Abbott Laboratories Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Gotham Asset Management, LLC holds 40,304 shares of ABT stock, worth $4.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

40,304

Previous 34,731 16.05%

Holding current value

$4.6 Million

Previous $3.61 Million 27.36%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $557,690 - $658,338	5,573 Added 16.05%	40,304 $4.6 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $32,837 - $36,655	326 Added 0.95%	34,731 $3.61 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $382,553 - $422,513	3,493 Added 11.3%	34,405 $3.91 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $52,039 - $63,700	-577 Reduced 1.83%	30,912 $3.4 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $381,069 - $457,219	-3,989 Reduced 11.24%	31,489 $3.05 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $3.03 Million - $3.38 Million	-30,060 Reduced 45.87%	35,478 $3.87 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $2.28 Million - $2.68 Million	-23,528 Reduced 26.42%	65,538 $6.64 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $1.31 Million - $1.54 Million	-13,799 Reduced 13.41%	89,066 $9.78 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.19 Million - $1.38 Million	-12,293 Reduced 10.67%	102,865 $9.95 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $443,902 - $536,536	4,349 Added 3.92%	115,158 $12.5 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $5.89 Million - $7.18 Million	51,671 Added 87.37%	110,809 $13.1 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $590,011 - $722,436	-5,107 Reduced 7.95%	59,138 $8.32 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $919,280 - $1.02 Million	7,880 Added 13.98%	64,245 $7.59 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $105,578 - $124,280	998 Added 1.8%	56,365 $6.53 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $733,690 - $864,398	6,741 Added 13.86%	55,367 $6.64 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $2.87 Million - $3.12 Million	-27,304 Reduced 35.96%	48,626 $5.32 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $1.67 Million - $2.02 Million	-18,170 Reduced 19.31%	75,930 $8.26 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1.79 Million - $2.29 Million	23,364 Added 33.03%	94,100 $8.6 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $3.82 Million - $5.58 Million	60,775 Added 610.13%	70,736 $5.58 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $207,501 - $230,998	2,643 Added 36.12%	9,961 $865,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $246,993 - $267,817	-3,018 Reduced 29.2%	7,318 $612,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $14.4 Million - $16.8 Million	-197,960 Reduced 95.04%	10,336 $869,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $3.18 Million - $3.84 Million	48,020 Added 29.96%	208,296 $16.7 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.53 Million - $1.74 Million	23,405 Added 17.1%	160,276 $11.6 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $1.9 Million - $2.29 Million	-31,204 Reduced 18.57%	136,871 $10 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $24.9 Million - $27.5 Million	-432,564 Reduced 72.02%	168,075 $10.3 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $14.5 Million - $16.3 Million	-256,844 Reduced 29.95%	600,639 $36 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $45.1 Million - $48.3 Million	839,632 Added 4703.56%	857,483 $48.9 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $857,919 - $957,527	17,851	17,851 $953,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account